Results summary | View all lists in GO:BiolProc | View all genes in C01A.profile.u50 |
The process whereby relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate. enrichment: 2.92-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
206675_S_AT | SKIL | D | R | S | SKI-like oncogene | ||||||||
201009_S_AT | TXNIP | X | E | thioredoxin interacting protein | |||||||||
37028_AT | PPP1R15A | G | X | protein phosphatase 1, regulatory (inhibitor) subunit 15A | |||||||||
204621_S_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
200797_S_AT | MCL1 | G | D | S | myeloid cell leukemia sequence 1 (BCL2-related) | ||||||||
204622_X_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
218192_AT | IHPK2 | G | inositol hexaphosphate kinase 2 | ||||||||||
218880_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
207826_S_AT | ID3 | D | R | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | |||||||||
36711_AT | MAFF | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | |||||||||
216248_S_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
201008_S_AT | TXNIP | X | E | thioredoxin interacting protein | |||||||||
201694_S_AT | EGR1 | D | R | early growth response 1 | |||||||||
202014_AT | PPP1R15A | G | X | protein phosphatase 1, regulatory (inhibitor) subunit 15A | |||||||||
201693_S_AT | EGR1 | D | R | early growth response 1 | |||||||||
201010_S_AT | TXNIP | X | E | thioredoxin interacting protein | |||||||||
208961_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 |